Detection and analysis of the safety profile of talazoparib based on FAERS database
Results of our study were consistent with clinical observations, and we also found potential new and unexpected AEs signals for talazoparib, suggesting prospective clinical studies were needed to confirm these results and illustrate their relationship. Our results may provide valuable evidence for further safety studies of talazoparib.
Authors
- Yang Li
- Peiyan Liu
- Lin-Zhe Du
- Jinjin Chen (ORCID: https://orcid.org/0000-0002-4912-0690)
- Yuanyuan Li (ORCID: https://orcid.org/0009-0001-4265-4008)
- Mufei Tang
Institutions
- Nanjing Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1080/14740338.2024.2392011
- Citations
- 1
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.28